These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2836349)
1. Mechanism of methotrexate-sensitivity of choriocarcinoma cells in culture. Inoue T; Nagura E; Toyoda T; Ishizuka T; Gotoh S; Kawashima K; Tomoda Y; Nagai Y Jpn J Cancer Res; 1988 Mar; 79(3):400-5. PubMed ID: 2836349 [TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells]. Sakai K Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate-induced resistance to dactinomycin in choriocarcinoma. Goto S; Okayama Y; Fan C; Ueda S; Saito M; Furuhashi Y; Ishizuka T; Tomoda Y Cancer; 1988 Sep; 62(5):873-7. PubMed ID: 3409169 [TBL] [Abstract][Full Text] [Related]
4. Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line. Han B; Xiang Y; Wang Y; Wang Z; Zhang H; Huang S Int J Gynecol Cancer; 2010 Oct; 20(7):1259-63. PubMed ID: 21495249 [TBL] [Abstract][Full Text] [Related]
5. Methotrexate-resistant mechanisms in human choriocarcinoma cells. Sakai K; Wake N; Fujino T; Yasuda T; Kato H; Fujimoto S; Fujinaga K Gynecol Oncol; 1989 Jul; 34(1):7-11. PubMed ID: 2737530 [TBL] [Abstract][Full Text] [Related]
6. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug. Srimatkandada S; Schweitzer BI; Moroson BA; Dube S; Bertino JR J Biol Chem; 1989 Feb; 264(6):3524-8. PubMed ID: 2914962 [TBL] [Abstract][Full Text] [Related]
7. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate]. Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154 [TBL] [Abstract][Full Text] [Related]
8. [The study of drug sensitivity on newly established three choriocarcinoma cell lines]. Okayama Y; Goto S; Fan C; Ueda S; Tomoda Y Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):17-23. PubMed ID: 3819510 [TBL] [Abstract][Full Text] [Related]
9. Development of methotrexate-resistant human choriocarcinoma cells in culture. Sekiya S; Kaiho T; Takamizawa H Gynecol Oncol; 1985 May; 21(1):46-53. PubMed ID: 4039287 [TBL] [Abstract][Full Text] [Related]
10. [MTX resistant mechanisms in human choriocarcinoma cells]. Sakai K; Fujino T; Hoshi S; Shinkai N; Hashimoto M; Yasuda T; Kato H; Yamada H; Wake N; Ichinoe K Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):807-14. PubMed ID: 3474305 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate. Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121 [TBL] [Abstract][Full Text] [Related]
12. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells. Miyachi H; Jiao L; Sowers LC; Scanlon KJ In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase. Bürkle A; Heilbronn R; zur Hausen H Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance. Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Tantravahi R; Ervin TJ; Frei E Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240 [TBL] [Abstract][Full Text] [Related]
15. Receptor binding of epidermal growth factor in cultured human choriocarcinoma cell lines: effects of actinomycin-D and methotrexate. Chen F; Goto S; Nawa A; Okamoto T; Tomoda Y Nagoya J Med Sci; 1990 Mar; 52(1-4):5-11. PubMed ID: 2381460 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
17. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells. Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117 [TBL] [Abstract][Full Text] [Related]
18. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy. Domin BA; Grill SP; Cheng Y Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441 [TBL] [Abstract][Full Text] [Related]
19. A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification. Saito H; Kishi K; Narita M; Furukawa T; Nagura E; Maekawa T; Abe T; Shibata A Leuk Res; 1992; 16(3):217-26. PubMed ID: 1560671 [TBL] [Abstract][Full Text] [Related]
20. Impaired drug uptake in methotrexate resistant Crithidia fasciculata without changes in dihydrofolate reductase activity or gene amplification. Dewes H; Ostergaard HL; Simpson L Mol Biochem Parasitol; 1986 May; 19(2):149-61. PubMed ID: 3724795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]